RetinAI

The company provides a cloud-based data management and artificial intelligence platform called Discovery for the ophthalmology and life sciences sectors. The software aggregates medical imaging and clinical data from multiple sources to perform automated analysis of biomarkers for diseases such as AMD, glaucoma, and diabetic retinopathy. Its tools support pharmaceutical companies in clinical trials and healthcare professionals in clinical workflows by harmonizing data and extracting insights on disease progression.